Free Trial

Treatt (LON:TET) Reaches New 52-Week High - Time to Buy?

Treatt logo with Basic Materials background

Treatt plc (LON:TET - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 527.25 ($6.61) and last traded at GBX 491 ($6.16), with a volume of 89169 shares trading hands. The stock had previously closed at GBX 515 ($6.46).

Analysts Set New Price Targets

Separately, Jefferies Financial Group restated a "buy" rating and issued a GBX 650 ($8.15) target price on shares of Treatt in a research note on Friday, December 6th.

Get Our Latest Stock Analysis on Treatt

Treatt Trading Down 4.7 %

The business's 50-day moving average is GBX 460.82 and its two-hundred day moving average is GBX 453.25. The company has a debt-to-equity ratio of 8.82, a current ratio of 2.83 and a quick ratio of 0.87. The firm has a market cap of £298.14 million, a P/E ratio of 2,727.78 and a beta of 1.02.

Treatt Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, March 13th. Stockholders of record on Thursday, February 6th will be issued a GBX 5.81 ($0.07) dividend. This is a boost from Treatt's previous dividend of $2.60. The ex-dividend date is Thursday, February 6th. This represents a dividend yield of 1.26%. Treatt's dividend payout ratio (DPR) is presently 4,444.44%.

Treatt Company Profile

(Get Free Report)

Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts and ingredients to the flavor, fragrance, beverage, and consumer product industries in the United Kingdom, Germany, Ireland, the United States, China, and internationally. The company offers flavor ingredients, such as citrus, coffee, tea, health and wellness, and fruits and vegetables extracts; Hics, aroma, and herb, spice, and floral ingredients.

Further Reading

Should You Invest $1,000 in Treatt Right Now?

Before you consider Treatt, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Treatt wasn't on the list.

While Treatt currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines